These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38641063)

  • 21. A role for ABCG2 beyond drug transport: Regulation of autophagy.
    Ding R; Jin S; Pabon K; Scotto KW
    Autophagy; 2016 May; 12(5):737-51. PubMed ID: 26983466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.
    Ji N; Yang Y; Lei ZN; Cai CY; Wang JQ; Gupta P; Xian X; Yang DH; Kong D; Chen ZS
    Biochem Pharmacol; 2018 Dec; 158():274-285. PubMed ID: 30431011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.
    Hassanein M; Qian J; Hoeksema MD; Wang J; Jacobovitz M; Ji X; Harris FT; Harris BK; Boyd KL; Chen H; Eisenberg R; Massion PP
    Int J Cancer; 2015 Oct; 137(7):1587-97. PubMed ID: 25821004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.
    Wu CP; Li YQ; Chi YC; Huang YH; Hung TH; Wu YS
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCI29732, a Bruton's Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells.
    Ge C; Wang F; Cui C; Su X; To KKW; Wang X; Zhang H; Song X; Fu L
    Cell Physiol Biochem; 2018; 48(6):2302-2317. PubMed ID: 30114704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
    Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
    Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer.
    Hasanabady MH; Kalalinia F
    J Biosci; 2016 Jun; 41(2):313-24. PubMed ID: 27240991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
    Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
    J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis Induced by the Curcumin Analogue EF-24 Is Neither Mediated by Oxidative Stress-Related Mechanisms nor Affected by Expression of Main Drug Transporters ABCB1 and ABCG2 in Human Leukemia Cells.
    Skoupa N; Dolezel P; Ruzickova E; Mlejnek P
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29088066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
    Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
    Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
    Lu H; Li X; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive Evaluation of Multidrug Resistance via Imaging of ABCG2/BCRP Multidrug Transporter in Lung Cancer Xenograft Models.
    Li C; Yang Q; Chen Z; Qiu Y; Du Y; Wang R; He Q; Yang J; Zhen H; Kang L
    Mol Pharm; 2022 Oct; 19(10):3521-3529. PubMed ID: 35427142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines.
    Wu CP; Lusvarghi S; Wang JC; Hsiao SH; Huang YH; Hung TH; Ambudkar SV
    Mol Pharm; 2019 Jul; 16(7):3040-3052. PubMed ID: 31117741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma.
    Tambay V; Raymond VA; Voisin L; Meloche S; Bilodeau M
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells.
    Yu T; Cheng H; Ding Z; Wang Z; Zhou L; Zhao P; Tan S; Xu X; Huang X; Liu M; Peng M; Qiu YA
    Mol Cell Endocrinol; 2020 Apr; 506():110762. PubMed ID: 32087276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs.
    Zhang W; Yang Y; Dong Z; Shi Z; Zhang JT
    J Biol Chem; 2019 Dec; 294(52):20222-20232. PubMed ID: 31719146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.
    Luo M; Wu L; Zhang K; Wang H; Zhang T; Gutierrez L; O'Connell D; Zhang P; Li Y; Gao T; Ren W; Yang Y
    Cell Death Differ; 2018 Aug; 25(8):1457-1472. PubMed ID: 29348676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
    Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells.
    Baglo Y; Liang BJ; Robey RW; Ambudkar SV; Gottesman MM; Huang HC
    Cancer Lett; 2019 Aug; 457():110-118. PubMed ID: 31071369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.